Basivertebral nerve ablation beneficial for chronic back pain

January 23, 2017

(HealthDay)—For patients with chronic lumbar back pain, ablation of the basivertebral nerve (BVN) improves self-reported outcome at three months and through one year, according to a study published in the February issue of The Spine Journal.

Stephan Becker, M.D., from the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in Vienna, and colleagues examined the efficacy of intraosseous BVN for treatment of chronic lumbar back pain. Seventeen patients with chronic for more than six months, which was unresponsive to at least three months of conservative care, were enrolled and 16 patients were treated successfully.

The researchers found that the mean baseline Oswestry Disability Index (ODI) was 52 ± 13 for the treated cohort, which decreased to a mean of 23 ± 12 at three months' follow-up (P < 0.001). This statistically significant improvement was maintained through 12 months of follow-up. There was a decrease in the mean baseline visual analogue scale score from 61 ± 22 to 45 ± 35 at three ' follow-up (P < 0.05), and an increase in the mean baseline physical component summary from 34.5 ± 6.5 to 41.7 ± 12.4 (P = 0.03).

"Ablation of the BVN for the treatment of chronic lumbar back significantly improves patients' self-reported outcome early in the follow-up period; the improvement persisted throughout the one-year study period," the authors write.

Two authors disclosed financial ties to Relievant Medsystems.

Explore further: AAPM: intradiscal biacuplasty improves outcomes in LBP

More information: Full Text (subscription or payment may be required)

Related Stories

AAPM: intradiscal biacuplasty improves outcomes in LBP

February 24, 2016
(HealthDay)—For patients with chronic low back pain (LBP) of discogenic origin, 12-month outcomes are superior for intradiscal biacuplasty plus conservative medical management (IDB+CMM) versus CMM alone, according to a ...

Platelet-rich plasma SIJ injection cuts low back pain

October 3, 2016
(HealthDay)—For patients with chronic low back pain, ultrasound-guided sacroiliac joint (SIJ) injection with platelet-rich plasma (PRP) is effective for reducing pain, according to a study published online Sept. 27 in Pain ...

Platelet-rich plasma superior for lumbar facet joint syndrome

December 28, 2016
(HealthDay)—For intra-articular injection autologous platelet-rich plasma (PRP) and local anesthetic (LA)/corticosteroid are effective, easy, and safe in the treatment of lumbar facet joint syndrome, according to a study ...

Oxiplex improves outcomes after lumbar discectomy

April 24, 2012
(HealthDay) -- The use of Oxiplex gel (containing carboxymethylcellulose, polyethylene oxide, and calcium) to coat the surgical site during discectomy procedures for the treatment of lumbar disc herniation is associated with ...

PCN, PRF both relieve pain in cervical disc herniation

September 26, 2016
(HealthDay)—For patients with contained cervical disc herniation, both percutaneous nucleoplasty (PCN) and pulsed radio frequency (PRF) are associated with pain relief, according to a study published online Sept. 9 in Pain ...

Lasting clinical results for total lumbar disc replacement

August 7, 2014
(HealthDay)—Total lumbar disc replacement (TDR) yields mid- to long-term clinical efficacy and patient satisfaction, according to a study published in the Aug. 1 issue of The Spine Journal.

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.